Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 USD | +20.21% | +28.41% | +3.57% |
May. 14 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
May. 14 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.57% | 283M | |
+7.38% | 111B | |
+11.13% | 106B | |
-12.46% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.79% | 16.81B | |
+37.54% | 12.54B | |
-24.36% | 8.09B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Poseida Therapeutics : Piper Sandler Adjusts Poseida Therapeutics PT to $19 From $17, Maintains Overweight Rating